Stock Screener
Best Stock Screener (Free)
Use our free stock screener to find investing opportunities based on your personalized filters. Contact us with feature suggestions, bug reports, and questions.

Ticker
Company
Exchange
Industry
Zen Rating
Market Cap
Price
1d %
EBITDA
P/E
D/E
Country
DD Score
LAFAU
LAFAYETTE ACQUISITION CORP
NASDAQ
Shell Companies
N/A$10.060.10%N/AN/A-5.79
EFTY
ETOILES CAPITAL GROUP CO LTD
NASDAQ
Consulting Services
N/A$15.020.00%$1.08M326.52x1.33
KLAR
KLARNA GROUP PLC
NYSE
Software - Infrastructure
N/A$36.91-1.20%N/AN/A7.13
United Kingdom
DKI
DARKIRIS INC
NASDAQ
Electronic Gaming & Multimedia
N/A$0.53-10.54%N/AN/A0.48
Hong Kong
STKE
SOL STRATEGIES INC
NASDAQ
Capital Markets
N/A$2.85-8.36%N/AN/A0.61
CHECU
CHENGHE ACQUISITION III CO
NASDAQ
Shell Companies
N/A$9.980.00%-$75.85k-499.00x-16.67
Cayman Islands
YCY.U
AA MISSION ACQUISITION CORP II
NYSE
Shell Companies
N/A$9.990.20%N/AN/A-18.87
United States
DMIIU
DRUGS MADE IN AMERICA ACQUISITION II CORP
NASDAQ
Shell Companies
N/A$10.02-0.30%N/AN/A-1.53
United States
LKSPU
LAKE SUPERIOR ACQUISITION CORP
NASDAQ
Shell Companies
N/A$10.06-0.10%N/AN/A-2.39
United States
DLXY
DELIXY HOLDINGS LTD
NASDAQ
Oil & Gas Refining & Marketing
N/A$1.030.19%$1.19M14.74x16.49
Singapore
LBRX
LB PHARMACEUTICALS INC
NASDAQ
Biotechnology
N/A$16.502.04%N/AN/A-0.09
United States
EMPG
EMPRO GROUP INC
NASDAQ
Medical Distribution
N/A$17.360.00%$1.51M157.82x4.10
Malaysia
CEPF
CANTOR EQUITY PARTNERS IV INC
NASDAQ
Shell Companies
N/A$10.50-0.10%N/AN/A-3.51
United States
NSRX
NASUS PHARMA LTD
NYSEMKT
Drug Manufacturers - General
N/A$8.005.12%-$1.50M-36.36x-1.22
Israel
AEXA
AMERICAN EXCEPTIONALISM ACQUISITION CORP A
NYSE
Shell Companies
N/A$11.31-1.05%N/AN/A6.16
United States
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.